Oppenheimer upgraded Endologix (NASDAQ: ELGX) from Perform to Outperform with a price target of $17.00.

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $12.36 yesterday.